1. Qiu Y, Zhu Q, Cui K, Wang H, Zhang W, Li X, Yu J, Li Y, Luo Y, Wang Y, Xie W, Xia Q, Xiao Z. Polymer-Based Raman/PET Dual-Modal Probe for Preoperative Tumor Diagnosis and Intraoperative Image-Guided Surgery and Phototherapy. ACS Appl Mater Interfaces. 2025 May 28;17(21):30613-30624. doi: 10.1021/acsami.5c03752. Epub 2025 May 13. PMID: 40359337. 2. Jingyi Wang; Liu Liu; Xinyu Gao; Xiyu Liu; Yitian Dai; Zijun Mao; Shengzhe Huang; Junjian Li; Dongliang Wang; Yu Qi; Yingwen Han; Yunjing Xu; Corrine Ying Xuan Chua; Alessandro Grattoni; Wenhui Xie; Hao Yang; Gang Huang ; A novel pathway for stemness propagation and chemoresistance in non-small cell lung cancer via phosphorylated PKM2 loaded small extracellular vesicles,Theranostics, 2025, 15(8): 3439-3461 3. Bei Lei, He Zhang, Jianwen Sun, Lihua Wang, Maomei Ruan, Hui Yan, Aimi Zhang, Cheng Chang, Hao Yang, Gang Huang, Liu Liu*, Wenhui Xie*. The potential of basal F-18-FDF PET/CT in evaluating prognosis and benefit from ajuvant chemotherapy after tumor resection of stage IB (T2, ≤ 3cm with VPI, N0, M0) NSCLC, Clin Lung Cancer,2025 Jan;26(1):18-28. e6. 4. Yan Zuo#, Liu Liu#, Cheng Chang, Pinzheng Huang, Hui Yan, Lihua Wang, Dazhen Sun, Maomei Ruan, Bei Lei, Xunpeng Xia, Kongyao Lu, Wenhui Xie, Shaoli Song*, Gang Huang*，Value of multi-center 18F-FDG PET/CT radiomics in predicting EGFR mutation status in lung adenocarcinoma.  2024 Jul;51(7):4872-4887. 5. Ruan M#, Chang C#, Sun J#, Liu L, Wang L, Lei B, Yan H, Zhang H, Xie W*, Wang Y*. Exploring the correlation between HER2 alterations and 18F-FDG PET/CT metabolic parameters and their prognostic value in EGFR-negative non-small-cell lung cancer patients. J Cancer Res Clin Oncol. 2023 Nov. 6. Yan H#, Wang L#, Lei B,Ruan M, Chang C,Zhou M, Liu L*, Xie W*, Wang Y*. The combination of SUVmax with clinical parameters improves diagnostic accuracy in distinguishing primary mediastinal lymphomas from thymic epithelial tumors，Quantitative Imaging in Medicine and Surgery，2023，accepted. 7. Sun X#, Chang C#, Xie C, Zhu J, Ni X, Xie W*, Wang Y*. Predictive value of SUVmax in visceral pleural invasive lung adenocarcinoma with different diameters. Nucl Med Commun. 2023 Nov. 8. X. Zhi,X. Sun,J. Chen,L. Wang,L. Ye,Y. Li,W. Xie*,J.Sun*, Combination of 18F-FDG PET/CT and convex probe endobronchial ultrasound elastography for intrathoracic malignant and benign lymph nodes prediction, Front Oncol,2022. 9. Yanna Cui#, Hui Yan#, Haoze Wang, Yongming Zhang, Meng Li, Kai Cui, Zeyu Xiao*, Liu Liu*, Wenhui Xie*, CuS-131I-PEG nanotheranostics-induced “multiple mild-hyperthermia”strategy to overcome radio-resistance in lung cancer brachytherapy. Pharmaceutics, 2022, 14(12), 2669. 10. C. Chang#, M. Ruan#, B. Lei, H. Yu, W. Zhao, Y. Ge, S. Duan, W. Teng, Q. Wu, X. Qian, L. Wang, H. Yan, C. Liu, L. Liu, J. Feng*, W. Xie*, Development of a PET/CT molecular radiomics-clinical model to predict thoracic lymph node metastasis of invasive lung adenocarcinoma </= 3 cm in diameter, EJNMMI Res 12(1) (2022) 23. Q2 11. X. Sun#, T. Chen#, C. Xie, L. Liu, B. Lei, L. Wang, M. Ruan, H. Yan, Q. Zhang, C. Chang*, W. Xie*, Relationships between SUVmax of lung adenocarcinoma and different T stages, histological grades and pathological subtypes: a retrospective cohort study in China, BMJ Open 12(5) (2022) e056804. Q2 12. Liu Liu#; Hui Yan#; Maomei Ruan; Hao Yang; Lihua Wang; Bei Lei; Xiaoyan Sun; Cheng Chang; Gang Huang*; Wenhui Xie*. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth. Cancer science, 2021;doi: 10.1111/cas.14988,online.Q2 13. Xiaoyan Sun#; Tianxiang Chen#; Cheng Chang; Haohua Teng; Chun Xie; Maomei Ruan; Bei Lei; Liu Liu; Lihua Wang; Yunhai Yang; Wenhui Xie*. SUVmax of 18FDG PET/CT Predicts Histological Grade of Lung Adenocarcinoma. Academic Radiology,2021;28(1):49-57. 14. Cheng Chang#; Xiaoyan Sun#; Gang Wang; Hong Yu; Wenlu Zhao; Yaqiong Ge; Shaofeng Duan; Xiaohua Qian; Rui Wang; Bei Lei; Lihua Wang; Liu Liu; Maomei Ruan; Hui Yan; Ciyi Liu; Jie Chen*; Wenhui Xie*. A machine learning model based on PET/CT radiomics and clinical characteristics predicts ALK rearrangement status in lung adenocarcinoma. Frontiers in Oncology,2021;11:603882. Q2 15. Cheng Chang#; Shihong Zhou#; Hong Yu; Wenlu Zhao; Yaqiong Ge;Shaofeng Duan;Rui Wang; Xiaohua Qian;Bei Lei; Lihua Wang;Liu Liu; Maomei Ruan; Hui Yan; Xiaoyan Sun*; Wenhui Xie*. A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma. European Radiology,2021.   16. Gang Liu#; Wenhui Xie#; Mingming Jin; Ping Li; Liu Liu; Lei Liu*; Gang Huang*, Transcriptome-based analyses revealed a WNT signature for the prognosis of non-small cell carcinoma. Aging, 2020;12(19):19159-19172. 17. Lihua Wang#; Maomei Ruan#; Bei Lei; Hui Yan; Xiaoyan Sun; Cheng Chang; Liu Liu*; Wenhui Xie*. The potential of 18F-FDG PET/CT in predicting PDL1 expression status in pulmonary lesions of untreated stage IIIB-IV non-small-cell lung cancer. Lung cancer,2020;150:44-52. 18. Lihua Wang#; Maomei Ruan#; Hui Yan; Bei Lei; Xiaoyan Sun; Cheng Chang; Liu Liu*; Wenhui Xie*. Pretreatment serum neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios: two tumor-related systemic inflammatory markers in patients with thymic epithelial tumors. Cytokine,2020;133:155149. 19. C. Chang, X. Sun, W. Zhao, R. Wang, X. Qian, B. Lei, L. Wang, L. Liu, M. Ruan, W. Xie*, J. Shen*, Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (</= 3 cm): PET/CT findings and correlations with lymph node metastasis, La Radiologia medica  (2019); 20. M. Ruan, L. Liu, L. Wang, B. Lei, X. Sun, C. Chang, Y. Shen*, W. Xie*, Correlation between combining(18)F-FDG PET/CT metabolic parameters and other clinical features and ALK or ROS1 fusion in patients with non-small-cell lung cancer, European journal of nuclear medicine and molecular imaging  (2020). 21. L. Liu, B. Lei, L. Wang, C. Chang, H. Yang, J. Liu, G. Huang*, W. Xie*, Protein kinase C-iota-mediated glycolysis promotes non-small-cell lung cancer progression, OncoTargets and therapy 12 (2019) 5835-5848. Q2 22. C. Chang, B. Ye, W. Xie*, D. Zhang, B. Lei, X. Ye. The diagnosis of silent myocardial ischemia. Motion-Frozen (or morphing) myocardial perfusion imaging. Hell J Nucl Med. 2016;19(3):196-199. 23. M. Ruan, M. Liu, L. Cheng, W. Xie*, L. Chen*, Increased 18F-FDG uptake of heterotopic pancreatitis in the small intestine A CARE-compliant case report Medicine 2016;95(36). 24. W. Xie, B. Zhang, L. Wang, C. Liu, C. Chang, B. Lei, Y. Wu*. Biodistribution characteristics and SPECT imaging of (99m)Tc-RET and (99m)Tc-REG in human lung cancer xenografts[J]. Cancer Biother Radiopharm. 2015;30(3):117-24. 25. X. Zhou, R. Chen, W. Xie, Y. Ni, J. Liu*, G. Huang*. Relationship Between 18F-FDG Accumulation and LactateDehydrogenase A Expression in Lung Adenocarcinomas. J Nucl Med 2014; 55:1766–1771. 26. X. Zhou#, W. Xie#, Q. Li, Y. Zhang, J. Zhang, X. Zhao, J. Liu*,G. Huang*.TIGAR Is Correlated with Maximal Standardized Uptake Value on FDG-PET and Survival in Non-Small Cell Lung Cancer. PLOS ONE. 2013;8(12):1-6. 27. W. Xie, C. Chang, Y. Xu,R. Li,X. Qu, W. Fang,X. Liu, Y. Yang*. Prevalence and spectrum of Nkx2.5 mutations associated with idiopathic atrial fibrillation. CLINICS. 2013;68(6):777-784. 28. S. Yang*, Q. Dong, M. Yao, M. Shi, J. Ye, L. Zhao, J. Su, W. Gu, W. Xie, K. Wang, Y. Du, Y. Li, Y. Huang*. Establishment of an Experimental Human Lung Adenocarcinoma Cell Line SPC-A-1BM with Highly Bone Metastases Potency by 99mTc-MDP Bone Scintigraphy. Nucl Med Biol,2009;6(3):313-321 29. J. ZENG*, C. Liu, W. Xie, S. Hu, X. Jin.Tissue-targeting lead generation and optimization from random and directed screening of technetium-99m labeled tri-peptide complex libraries in vivo. Chin Med J, 2006;119 (17):1435-1443 30. B. Zhao, J. Cao, J. Shao, Y. Sun, L. Fan, C. Wu, S. Liang, B. Guo,G. Yang, W. Xie, Q. Yang, S. Yang*. Novel esophageal squamous cell carcinoma bone metastatic clone isolated by scintigraphy, X ray and micro  PET/CT. World J Gastroenterol,2014, 20(4):1030-7 31. X. Qu, W. Fang*, K. Gong, J. Ye, S. Guan,R. Li, Y. Xu, Y. Shen, M. Zhang, H. Liu, W. Xie. Clinical Significance of A Single Multi-Slice CT Assessment in Patients with Coronary Chronic Total Occlusion Lesions Prior to Revascularization. PLoS One. 2014; 9(6): e98242.